For more than two decades, the biomedical company Pfizer has been working in the research and development of treatments to respond to the unmet medical needs of people living with rare diseases.

You can learn more about it here:

https://www.pfizer.es/noticia/pfizer_mendelian_presentan_una_plataforma_tecnologica_apoyar_profesionales_sanitarios_investigacion_diagnostico_enfermedades_raras.html



Need help with a diagnosis?

Learn more about how to achieve it with Mendelian


Learn more

Other blog that you may find interesting

Empowering doctors in rare disease diagnosis Technology that is changing the face of first line healthcare Rare diseases 101 - Systemic Amyloidosis